Single Infrapubic Versus Bilateral Subinguinal Microsurgical Varicocelectomy
Single Infrapubic Versus Bilateral Subinguinal Approaches for Bilateral Microsurgical Varicocelectomy: A Prospective Randomized Controlled Trial
Bilateral varicocele is commonly treated by microsurgical varicocelectomy. The conventional bilateral subinguinal approach usually requires two separate skin incisions, one on each side. A single midline infrapubic approach may allow bilateral microsurgical repair through one incision and may reduce access-related morbidity.
This prospective randomized controlled trial will compare single infrapubic microsurgical bilateral varicocelectomy with conventional bilateral subinguinal microsurgical varicocelectomy in adult men with clinically palpable bilateral varicocele. The study will evaluate postoperative pain, analgesic requirement, time to return to normal daily activity, operative time, scar satisfaction, wound complications, recurrence, and other safety outcomes during follow-up.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Hany F Badawy, MD
- 电话号码:+201149525028
- 邮箱:HANYFATHY86@GMAIL.COM
学习地点
-
-
Beni Suweif Governorate
-
Banī Suwayf、Beni Suweif Governorate、埃及、02456
- 招聘中
- Department of Urology- Beni-Suef University Hospitals
-
接触:
- Hany F Badawy, MD
- 电话号码:+201149525028
- 邮箱:HANYFATHY86@GMAIL.COM
-
首席研究员:
- Hany F Badawy, MD
-
接触:
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Male patients aged 18 to 45 years.
- Clinically palpable bilateral varicocele, grade II or grade III.
- Diagnosis confirmed by color Doppler ultrasound.
- Infertility for at least 12 months and/or abnormal semen analysis.
- Female partner evaluation performed or planned to exclude major uncorrected female-factor infertility.
- Patient fit for surgery and anesthesia.
- Written informed consent provided by the participant.
Exclusion Criteria:
- Subclinical varicocele detected only by Doppler ultrasound.
- Unilateral varicocele.
- Recurrent varicocele after previous surgery, embolization, or sclerotherapy.
- Previous inguinal, scrotal, pelvic, or penile surgery likely to distort surgical anatomy.
- Associated inguinal hernia, hydrocele, spermatocele, epididymal cyst, or other scrotal condition requiring simultaneous surgery.
- Azoospermia, especially suspected non-obstructive azoospermia.
- Active urinary tract or genital infection.
- Coagulopathy or anticoagulant therapy that cannot be safely interrupted.
- Severe obesity, defined as body mass index greater than 40 kg/m², or any anatomical condition preventing safe exposure by either surgical approach.
- Refusal to participate or inability to complete follow-up.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Single Infrapubic Microsurgical Bilateral Varicocelectomy
Participants allocated to this arm will undergo bilateral microsurgical varicocelectomy through a single midline infrapubic skin incision.
The right and left spermatic cords will be approached sequentially through the same incision under microscopic or high-magnification surgical loupes with microsurgical capability.
Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
|
Bilateral microsurgical varicocelectomy performed through a single midline infrapubic skin incision.
The right and left spermatic cords will be approached sequentially through the same incision under microscopic or high-magnification surgical loupes with microsurgical capability.
Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
|
|
有源比较器:Bilateral Subinguinal Microsurgical Varicocelectomy
Participants allocated to this arm will undergo conventional bilateral subinguinal microsurgical varicocelectomy through two separate standard subinguinal incisions, one on each side.
Each spermatic cord will be isolated at the subinguinal level under microscopic or high-magnification surgical loupes with microsurgical capability.
Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
|
Conventional bilateral microsurgical varicocelectomy performed through two separate standard subinguinal incisions, one on each side.
Each spermatic cord will be isolated at the subinguinal level under microscopic or high-magnification surgical loupes with microsurgical capability.
Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Postoperative Pain Score
大体时间:6 hours, 24 hours, and 7 days after surgery
|
Postoperative pain will be assessed using the Visual Analog Scale.
The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate worse postoperative pain.
|
6 hours, 24 hours, and 7 days after surgery
|
|
Analgesic Requirement
大体时间:During the first 7 postoperative days
|
Analgesic requirement will be assessed by recording the total number and dose of analgesic tablets and/or injections consumed by the participant during the first 7 postoperative days.
Higher analgesic use indicates greater postoperative analgesic requirement.
|
During the first 7 postoperative days
|
|
Time to Return to Normal Daily Activity
大体时间:From surgery until return to normal daily activity, assessed up to 30 days after surgery
|
Time to return to normal daily activity will be defined as the number of days from surgery until the participant resumes usual non-strenuous daily activities.
A shorter time indicates faster postoperative recovery.
|
From surgery until return to normal daily activity, assessed up to 30 days after surgery
|
|
Total Operative Time
大体时间:During surgery
|
Total operative time will be defined as the time from skin incision to completion of skin closure, measured in minutes.
|
During surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Scar Satisfaction and Cosmetic Outcome
大体时间:6 months after surgery
|
Scar satisfaction and cosmetic outcome will be assessed using the Patient and Observer Scar Assessment Scale version 2.0.
The scale includes two components: the Patient Scale and the Observer Scale.
The Patient Scale assesses pain, itching, color, stiffness, thickness, and irregularity.
The Observer Scale assesses vascularity, pigmentation, thickness, relief, pliability, and surface area.
Each item is scored from 1 to 10, where 1 indicates normal skin or no symptoms and 10 indicates the worst imaginable scar or the greatest difference from normal skin.
The total score for each component ranges from 6 to 60. Higher scores indicate worse scar quality and lower scar satisfaction.
|
6 months after surgery
|
|
Varicocele Recurrence
大体时间:6 months after surgery
|
Varicocele recurrence will be assessed by clinical examination and/or color Doppler ultrasound.
Recurrence will be reported as the number and percentage of participants with recurrent varicocele.
|
6 months after surgery
|
|
Conversion or Access Failure
大体时间:During surgery
|
Conversion or access failure will be recorded when the allocated surgical approach cannot be completed as planned and an additional or alternative incision or approach is required to safely complete the procedure.
|
During surgery
|
|
Wound Complications
大体时间:Up to 30 days after surgery
|
Wound complications will be assessed by recording the occurrence of surgical site infection, hematoma, seroma, wound dehiscence, or delayed wound healing.
The outcome will be reported as the number and percentage of participants with any wound complication.
|
Up to 30 days after surgery
|
合作者和调查者
调查人员
- 首席研究员:Hany F Badawy, MD、Faculty of medicine Beni-Suef University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- BSU-INFRAP-VARICO-2026
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.